Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Incyte to Present at Upcoming Investor Conference By: Incyte via Business Wire August 23, 2022 at 08:00 AM EDT Incyte (Nasdaq:INCY) announced today that it will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 at 12:30 p.m. (EDT) in New York. The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days. About Incyte Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte. View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005001/en/Contacts Incyte Media Catalina Loveman +1 302 498 6171 cloveman@incyte.com Investors Christine Chiou +1 302 274 4773 cchiou@incyte.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Incyte to Present at Upcoming Investor Conference By: Incyte via Business Wire August 23, 2022 at 08:00 AM EDT Incyte (Nasdaq:INCY) announced today that it will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 at 12:30 p.m. (EDT) in New York. The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days. About Incyte Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte. View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005001/en/Contacts Incyte Media Catalina Loveman +1 302 498 6171 cloveman@incyte.com Investors Christine Chiou +1 302 274 4773 cchiou@incyte.com
Incyte (Nasdaq:INCY) announced today that it will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 at 12:30 p.m. (EDT) in New York. The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days. About Incyte Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte. View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005001/en/
Incyte Media Catalina Loveman +1 302 498 6171 cloveman@incyte.com Investors Christine Chiou +1 302 274 4773 cchiou@incyte.com
